Medicine
Tradjenta 5 mg tablet
Tradjenta 5 mg tablet is a prescription medicine containing Linagliptin for oral use, marketed by Boehringer Ingelheim Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Linagliptin
- Brand
- Tradjenta
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 blister pack, 90 tablets and 2 more
- Marketing authorisation holder
- Boehringer Ingelheim Pharmaceuticals
- Manufacturers
- Boehringer Ingelheim PharmaceuticalsA-S Medication SolutionsCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BH05 Linagliptin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2011
- Identifiers
- RxCUI 1100702, 1100706DailyMed set ID dfe327e8-f6ab-41e5-bdef-d520118cd83a, b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1, c797ea5c-cab7-494b-9044-27eba0cfe40fNDC 55154-0410, 50090-4383, 0597-0140Application NDA201280
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0597-0140-30 | Boehringer Ingelheim Pharmaceuticals | 9 May 2011 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0597-0140-61 | Boehringer Ingelheim Pharmaceuticals | 9 May 2011 |
| 90 tablet, film coated in 1 bottle | 0597-0140-90 | Boehringer Ingelheim Pharmaceuticals | 9 May 2011 |
| 90 tablet, film coated in 1 bottle | 50090-4383-0 | A-S Medication Solutions | 24 June 2019 |
| 2640 tablet, film coated in 1 bottle, plastic | 55154-0410-8 | Cardinal Health | 9 May 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Linagliptin is a dipeptidyl peptidase 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Linagliptin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LinagliptinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tradjenta prescribing information (Boehringer Ingelheim Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Trajenta: European public assessment report (EPAR) · European Medicines Agency
Need Tradjenta 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.